Phase III Study to Evaluate the Immunogenicity and Safety of MG1109 in Healthy Adult Volunteers
Clinical trial NCT01987011 · COMPLETED
Trial details
- NCT number
- NCT01987011
- Sponsor
- Green Cross Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2013-10-01
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.